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Abstract.  Heparin-binding growth factor-2 (HBGF-2; 
also known as basic fibroblast growth factor) is mito- 
genic for most anchorage-dependent cells. It is shown 
here that HBGF-2 stimulates ceil-substratum adhesion 
and neurite extension in the sympathetic nerve cell 
line PC12.  When HBGF-2 is adsorbed to artificial ex- 
tracellular matrices consisting of heparin or chondroi- 
tin sulfate, it causes the formation of cellular ag- 
gregates or circles of cells, respectively. HBGF-2 is 
also a  nerve cell survival molecule, for it potentiates 
the survival of primary cultures of embryonic chick 
ciliary ganglion cells but not of embryonic neural ret- 
ina cells. Finally, a  series of synthetic peptides from 
the HBGF-2 sequence is described that selectively al- 
ter the biological effects of HBGF-2. The amphiphilic 
nature of one of these peptides is discussed with re- 
spect to its ability to stimulate cell adhesion. 
variety of molecules have been described that can alter 
the  differentiation and  survival  of cultured nerve 
cells.  These  include nerve  growth  factor (NGF ~, 
27)  laminin-like molecules (7,  21,  25,  31), S10013 (24),  a 
ciliary ganglion survival factor (5,  36),  purpurin (43, 44, 
46), and a 12,300-D protein that supports the survival of em- 
bryonic chick sensory neurons (6). In addition, gangliosides 
(35) and several other low molecular weight molecules can 
promote the differentiation and survival of cultured cells. To 
date only three of these trophic molecules have been fully se- 
quenced: NGF (2), S10013 (24),  and purpurin (Berman, P., 
E Gray, E. Chen, M. LaCorbiere, F. Esch, and D. Schubert, 
manuscript submitted for publication). 
In addition to the above trophic molecules, at least two low 
molecular weight heparin-binding mitogens have been puri- 
fied to homogeneity from the central nervous system. The 
first is a 16,000-D protein with a pI of 5.8 (51) and the second 
is a basic 16,400-D protein (16) whose activity was initially 
described by Armelin (3).  The primary structures of both 
have been recently determined (16, 17). Because these pro- 
teins are structurally distinct but similar in size and heparin- 
binding activity to purpurin, a nerve cell survival and adhe- 
sion molecule from the chick neural retina (46),  the effect 
of the basic pituitary heparin-binding growth factor (the term 
HBGF-2 according to the nomenclature of Lobb et al. [30] 
is used here; also known as basic fibroblast growth factor) 
on nerve cell survival, adhesion, and differentiation was as- 
sayed in primary and clonal cell cultures. It will be shown 
that HBGF-2 causes nerve cell adhesion and differentiation, 
that it promotes the survival of some but not all classes of 
neurons, and that it induces simple social interactions be- 
1. Abbreviations  used in this paper: HBGF-2, heparin-binding growth fac- 
tor; NGF,  nerve growth factor. 
tween cells. Synthetic peptides derived from the HBGF-2 
sequence have been developed which can alter each of these 
events. 
Materials and Methods 
Cells and Cultures 
PCI2 ceils, clone H, were obtained from Dr. H. Hatanaka, Mitsubishi-Kasei 
Institute, Tokyo (20) and grown on tissue culture plastic in 10% FCS plus 
5 % horse serum. Neural retina tissue was separated from the pigmented epi- 
thelium of 8-d leghorn chick embryos and incubated in  Hepes-buffered 
DME with 0.5%  (wt/vol) crude trypsin (Nutritional Biochemical Corp., 
Cleveland, OH) for 20 min at 37"C. The cells were then rinsed three times 
with DME and placed in polylysine-coated tissue culture dishes with or 
without the indicated growth factors. The ciliary ganglion survival assay 
was performed as described (5,  14). Briefly,  35-ram tissue culture dishes 
(Falcon Labware, Becton, Dickinson & Co., Oxnard, CA) were precoated 
with 2 ml ofa polyornithine solution (100 p.g/ml in 0.15 M borate, pH 8.5) 
overnight at 4°C. The dishes were washed twice with DME and seeded with 
5,000 cells from 8-d embryonic chick ciliary ganglion per dish in DME plus 
10% FCS and the test compound. 24 h later cultures were assayed for viable 
cells either by direct visual count under phase contrast microscopy or with 
the use of 3-(4,5-dimethylthiazol-2-yl) 2,5 diphenyl tetrazolium bromide 
(32).  The data are presented as the percent of the survNing input cells. 
Adhesion Assays 
To assay cell-substratum adhesion, PCI2 cells were metabolically labeled 
with [3H]leucine  (5 t~Ci/ml) in DME plus serum for 15 h. The cells were 
washed three times with Hepes medium containing 0.3% BSA, (Calbio- 
chem-Behring Corp., San Diego, CA), and 0.2-ml aliquots were pipetted 
into 35-mm Petri dishes to which HGBF-2 had been adsorbed. At the indi- 
cated times the dishes were swirled 10 times, the medium was aspirated, 
and the remaining attached cells were dissolved in 3 % Triton X-100 and their 
isotope content was determined. The data are plotted as the fraction of input 
cells (radioactivity) that adhered at the indicated time. Variations between 
duplicates were <5%. 
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The HBGF-2 used in all experiments was purified as described by Esch et 
al. (16) and was a chromatographically pure 16,400-D protein. 100-150 pmol 
of HBGF-2 were iodinated by the lactoperoxidase method (50).  The iodi- 
nated growth factor was purified by heparin-sepharuse affinity chromatog- 
raphy and the peak of radioactivity eluting with 2 M  NaC1 was used in all 
studies. The specific activity of the iodinated growth factor was >100,000 
cpm/ng. The ~2SI-HBGF-2 was stored at 4°C and was stable for 2 wk. 
To assay ~2SI-HBGF-2 binding, PC12  cells were seeded at high density 
(1-2  ×  l0  s cells/well) in 48-miniwell dishes that had been precoated with 
polylysine. The following day the cells were washed twice with binding 
buffer (F12 medium, 25 mM Hepes, pH 7.5, 0.2% gelatin) and incubated 
in 200 Ixl of the same buffer.  ~2SI-HBGF-2 was then added to the cells in 
a total volume of 10 Ixl. Both total and nonspecific binding were determined 
in quadruplicate or sextuplet wells. The cells were incubated for the indi- 
cated times at 4°C and the reaction was terminated by three washes with 
binding buffer. Cells were solubilized with 200 I.tl of 1% Triton X-100 in 
water and an aliquot was removed and counted on a "/-counter.  Nonspecific 
binding to the ceils, as determined by the inhibition of ~2sI binding by 4 I-tg 
of HBGF-2, was <20%  of the total binding. 
Preparation of  Arttficial Matrix 
An artificial matrix was created to assay the ability of substratum bound 
HBGF-2 to influence the morphological differentiation of PC12 cells. Poly- 
L-lysine (Sigma Chemical Co., St. Louis, MO) was incubated at 50 I.tg/ml 
overnight in 35-ram tissue culture dishes (Falcon Labware). The dishes were 
washed twice with water and incubated overnight with either heparin (por- 
cine intestinal mucosa, Grade 1, Sigma Chemical Co.) or chondroitin sul- 
fate A (Miles Laboratories, Inc., Elkhart, IN) at 200 ~tg/ml. The following 
day  the dishes were  washed twice  with water  and  incubated in  Hepes- 
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Figure 1. Displacement of cell-associated ~25I-HBGF-2 by pituitary 
HBGF-2.  PC12 ceils were incubated with 4  ng/ml of ~25I-HBGF-2 
and increasing concentrations of urdabeled HBGF-2 for 2 h at 4°C. 
The binding was performed as described in Materials and Methods. 
10%  of the input ~2SI-HBOF-2 bound to the cells in the absence of 
other peptides. 
buffered DME overnight with 1 pmol/dish of HBGF-2. Greater than 95% 
of the input HBGF-2 bound to each surface as determined by the inclusion 
of ~25I-HBGF-2. Finally, the dishes were washed twice with DME and the 
cells incubated on these surfaces in serum-free N2 medium (10). 
Table I. Synthetic Fragments of HBGF-2 
Inhibition of  Stimulation 
Peptide  Fragment  Sequence  Peptide  Charge  HBGF-2 binding  of adhesion 
%  % 
A  [Tyr  I°]  (1-10)OH  PALPEDGGSY  A  -2  NS  40 
B  [Tyr  5°] (30-50)NH2  FFLRIHPDGRVDGVREKSDPY  B  + 1  11  NS 
C  [Tyr  69,87] (69-87)NH2  YANRYLAMKEDGRLLASKY  C  +3  NS  NS 
D  (106-115)NH2  YRSRKYSSWY  D  +4  60  80 
E  (1-24)NH2  PALPEDGGSGAFPPGHFKDPKRLY  E  + 1  12  230 
F  (24-68)NH2  YCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQ  F  +3  A  60  450 
AEERGVVSIKGV 
F ~  [Tyr  2s] (25-68)NH2  YKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQA  F ~  +3  A  95  450 
AEERGVVSIKGV 
G  [Tyr  sT] (73-87)NH2  YLAMKEDGRLLASKY  G  +2  NS  NS 
H  (121-146)NH2  TGQYKLGPKTGPGQKAILFLPMSAKS  H  +5  A  NS  NS 
I  (16-24)NH2  HFKDPKRLY  I  +3  12  20 
J  (36-39)NH2  PDGR  J  + 1  NS  - 
K  (30-39)NH2  FFLRIHPDGR  K  +2  6  NS 
K ~  (32-39)NH2  LRIHPDGR  K 1  +2  5  NS 
M  (32-53)NH2  LRIHPDGRVDGVREKSDPHIKL  M  +2  NS  NS 
N  (93-120)NH2  FFFERLESNNYNTYRSRKYSSWYVALKR  N  +5  82  480 
N t  (103-120)NH2  YNTYRSRKYSSWYVALKR  N ~  +6  80  460 
Complete sequence: 
10  20  30  40  50  60  70  80 
PALPEDGGSG  AFPPGHFKDP  KRLYCKNGGF  FLRIHPDGRV  DGVREKSDPH  IKLQLQAEER  GVVSIKGVCA  NRYLAMKEDG 
90  100  110  120  130  140  146 
RLLASKCVTD  ECFFFERLES  NNYNTYRSRK  YSSWYVALKR  TGQYKLGPKT  GPGQKAILFL  PMSAKS 
Peptides were synthesized as described in Materials and Methods and tested for their ability  to block HBGF-2 binding and to stimulate adhesion. To determine 
the effect of the peptides on HBGF-2 binding, PC12 cells were incubated for 10 min at 4°C in the presence of the indicated  synthetic peptides, followed by the 
addition of ~25I-HBGF-2. The amount of HBGF-2 binding was determined as in Materials and Methods and the data represented as the percent inhibition of bind- 
ing by the peptides relative to the control cultures. Peptides were used at 100 I.tg/well. To assay the stimulation of cellular adhesion by synthetic peptide fragments 
of HBGF-2, the indicated peptides were adsorbed to plastic petri dishes at 300 I.tg/35-mm culture dish. All of the input peptides, except J, adhered to the plastic 
as determined by HPLC or protein analysis. The adhesion of input cells after 1-h incubation  was determined as in Fig. 2 and presented as the percent stimulation 
relative  to neutral petri dish surfaces where 6-8% of the input cells adhered. All experiments were repeated  at least three times with  similar results. NS,  not 
significant.  A, amphiphilic. 
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All HBGF-2 peptides were prepared by solid phase methods (34) using the 
methylbenzhydrylamine  resin.  The  exception  was  the  [Tyr  ~j  (1-10)OH 
fragment that was made with a N*-Boc-(2,6-dichlorobenzyl) tyrosine cou- 
pled chloromethyl resin (28). The synthetic products were purified by gel 
filtration, ion-exchange, and partition chromatography as described else- 
where (29). Fragments F and F 1 were also purified by preparative HPLC. 
The purified products had the correct amino acid composition and the purity 
ranged from 90 to 98%  by HPLC  analysis. 
Results 
HBGF-2 Binding to Cells 
HBGF-2 is mitogenic for essentially all of the anchorage- 
dependent cultured cells on which it has been tested,  sug- 
gesting that it interacts with a relatively common cell surface 
receptor. To determine if HBGF-2 can bind to nerve cells, 
HBGF-2 was labeled with 1251 and its ability to bind to the 
NGF-responsive PC12 cell line assayed, tzSI-HBGF-2 binds 
to PC12  cells in a time dependent manner, with maximum 
binding occurring at 2 h.  Fig.  1 shows that the binding of 
t25I-HBGF-2  is  inhibited  by the  unlabeled  molecule  with 
50%  displacement at  ~7 pmol/well (3.5  x  10  -s M).  The 
iodinated HBGF-2 is as mitogenic as the native molecule for 
endothelial  cells.  Neither  NGF  nor  the  heparin  binding 
adhesion molecule N-CAM (12) competes with HBGF-2 for 
binding to the cell surface when tested at 5  ~tg/ml. 
Since HBGF-2 has been recently sequenced (16), it is pos- 
sible to synthesize peptide fragments that cover the complete 
primary structure of the molecule and to ask if any of these 
synthetic peptides can alter the cell binding or biological ac- 
tivity of HBGF-2. In this manner it may be possible to define 
which parts of the molecule are responsible for its diverse 
actions. Table I shows the structure of HBGF-2 and the syn- 
thetic peptides,  which are identified by a  letter code.  The 
peptides with a net charge are indicated and the amphiphilic 
or  13-sheet (alternating  hydrophobic  and  hydrophilic  resi- 
dues) sequences marked by the letter A. There are two am- 
phiphilic  stretches  of  amino  acids  (residues  34--41 and 
49-58) in peptide F and one sequence (residues 123-133)  in 
peptide H  toward the COOH-terminus. 
To determine which parts of the HBGF-2 primary struc- 
ture are involved in cell binding, the ability of each peptide 
to  block  t25I-HBGF-2  binding  was  determined.  Peptides 
were used at a concentration of 100 ~tg/ml or '~5  x  10  -5 M 
for a 20-residue peptide. Table I shows that only peptides D 
(residues  106-115),  F  and F 1 (residues 24-68),  and N  and 
N t (residues 93,  103-120)  are very effective in inhibiting the 
HBGF-2-cell interaction.  It is shown elsewhere that these 
peptides interact strongly with heparin (4); heparin can also 
block the binding of HBGF-2 to cells at a concentration of 
1 IJg/ml. These results suggest that the HBGF-2-cell surface 
interaction may require an interaction of the growth factor 
with a cell surface heparin or heparan sulfate proteoglycan. 
PC12 Cell-Substratum Adhesion 
Cell-substratum adhesiveness plays a critical role in the initi- 
ation of neurite outgrowth in many types of cultured cells and 
on the rate of neurite outgrowth of all cultured nerve cells 
(see, for example, 26,  41, 42).  To determine if substratum- 
bound HBGF-2 alters the adhesiveness of PC12  cells to an 
adhesive neutral surface, low density exponentially dividing 
PC12  cells were labeled overnight with [3H]leucine, plated 
onto petri dish surfaces that had been coated with 30 pmol 
of HBGF-2, and the percent of input cells that adhered to the 
HBGF-2 substratum were assayed as a function of time. Fig. 
2 A shows that HBGF-2 stimulates the adhesion of PC12 cells 
relative to the petri dish surface alone. The concentration de- 
pendence of this adhesion is shown in Fig. 2 B. The half max- 
imal rate of adhesion to HBGF-2 is at a HBGF-2 concentra- 
tion of 10 pmol/35-mm petri dish. The glycosaminoglycans 
heparin and heparan sulfate block the adhesion of PC12 cells 
to HBGF-2, but chondroitin sulfate is ineffective. There is 
some specificity with respect to the ability of heparin to in- 
hibit adhesion, for heparin is only marginally effective in in- 
hibiting the adhesion of PC12 cells to laminin and fibronec- 
tion (1; Schubert, D., unpublished observation). HBGF-2 is 
therefore an adhesion protein for nerve cells and it is effective 
in causing adhesion in the picomole range. 
To understand  which  parts  of the  primary sequence  of 
HBGF-2 are responsible for promoting the HBGF-2-cell in- 
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Figure 2. Stimulation of cell-sub- 
stratum adhesion by HBGF-2. The 
adhesion  of isotopically  labeled 
PC12  cells  to  HBGF-2-coated 
surfaces  was determined  as  de- 
scribed  in  Materials  and  Meth- 
ods. (A) Adhesion of PC12 cells 
to substrata  containing  30 pmol 
of HBGF-2 as a function of time. 
(X)  Petri dish  alone;  (open cir- 
cles)  HBGF-2;  (open squares) 
HBGF-2 plus 200 I.tg/ml  of chon- 
droitin  sulfate;  (open triangles) 
HBGF-2 plus 200 ~tg/ml of hepa- 
ran  sulfate. (B)  Concentration 
dependence  of  adhesion.  Petri 
dishes were coated with the indi- 
cated concentrations  of HBGF-2 
and the percent of input cells ad- 
hered determined  after 1 h. 
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PC12 neurite outgrowth. PC12 cells 
were  plated  on  polylysine-coated 
surfaces  in  serum-free  N2  medi- 
um as described in Materials and 
Methods.  The  phase photomicro- 
graphs were taken 3 d after the ad- 
dition  of the  growth  factors.  (A) 
Control.  (B)  I3-NGF at  10 ng/ml. 
(C) HBGF-2 at 50 pM. (D) HBGF- 
2  plus  100  txg/ml  of  peptide  F 
(24-68). 
teraction,  100 ~tg/ml of each synthetic peptide (Table I) was 
added to the culture dishes containing HBGF-2 bound to the 
substratum before the addition  of cells.  Of the  16 peptides 
tested, none blocked the adhesion of PC12 cells to HBGF-2. 
However, several did slightly  stimulate the rate of adhesion 
over a  period of 1 h.  Since it is possible that the synthetic 
peptides adhere to the  substratum  during  the course of the 
assay  and  promote  cell-substratum  adhesion  rather  than 
block it, the longer synthetic peptides were adsorbed to the 
surface of petri dishes and assayed for their ability to stimu- 
late cell adhesion.  Table I shows that the amphiphilic 24-68 
sequence  (peptides F  and F 1) and the peptide sequence be- 
tween residues 93 and  120 (peptide N) are very effective at 
stimulating  cell-substratum  adhesion.  Charge  and  amphi- 
philicity alone is not,  however, responsible for the stimula- 
tion of adhesion,  for the highly positively charged and am- 
phiphilic  peptide  H  (residues  121-146)  does  not  stimulate 
adhesion.  Except for the NH2-terminal (residues  1-24) pep- 
tide,  the other peptides  are ineffective.  These data  suggest 
that although peptides F and N block the binding of HBGF-2 
to cells, they do not interfere with substratum-bound HBGF- 
2-cell adhesion because they are rapidly adsorbed to the sub- 
stratum themselves and promote adhesion. 
Morphological Differentiation of  PC12 Cells 
When  NGF is added  to exponentially  dividing  PC12  cells, 
they respond by the extension  of neurites  (Fig.  3 B).  PC12 
ceils also respond to HBGF-2 by extending neurites  (Fig.  3 
C). The concentration of HBGF-2 required to give the maxi- 
mum  rate  of neurite  extension  is  "-25  pM  (Table II),  and 
there is no alteration in the response if concentrations 50-fold 
higher  are  used.  Neurite  outgrowth  continues  for  several 
days in the presence of HBGF-2 and, as with NGF, is revers- 
ible when  the growth  factor is removed.  At lower concen- 
trations of HBGF-2 neurite outgrowth ceases after a few days 
and  the  neurites  retract  (Table  II).  Repeated  addition  of 
HBGF-2  allows  neurite  outgrowth  to  continue  for up  to  a 
week and it ceases only when the cell density becomes high, 
leading  to cell detachment. 
To  determine  which  part  of  the  HBGF-2  molecule  is 
responsible for the induced neurite outgrowth,  the synthetic 
peptides were examined for their ability to block HBGF-2 in- 
duced neurite outgrowth.  Only peptides  F  and F ~ (Table I) 
Table II. HBGF Titration on Neurite Outgrowth 
Days 
HBGF  1  2  3  4  5 
pM 
500  +  +  +  +  + 
250  +  +  +  +  + 
100  +  +  +  +  + 
50  +  +  +  +  - 
25  +  +  +  -  - 
10  +  +  -  -  - 
5  +  +  -  -  - 
2.5  +  .... 
1  ..... 
Cells were plated on polylysine-coated  dishes in N2 medium and HBGF added 
at the indicated concentrations. The presence of neurites was scored on the fol- 
lowing days in at least 200 cells. A plus sign indicates that at least half of the 
cells within population had neurites >1  cell diameter (20 I~m). 
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growth (Fig. 3 D). None of the other synthetic peptides has 
any obvious effect on the HBGF-2-induced morphological 
differentiation of the  PC12  cells when tested at concentra- 
tions up to 200 ~tg/ml,  nor do any of the peptides cause neu- 
rite outgrowth when added directly to the culture medium or 
when adsorbed to the culture dish substratum before plating 
of the cells. 
HBGF-2-induced neurite formation is completely blocked 
by 100 Ixg/ml of heparin but not by chondroitin sulfate. Neu- 
rite formation induced by NGF on polylysine surfaces is also 
reduced in the presence of 100 ~tg/ml heparin or heparan sul- 
fate but  not  completely elminated  as  it  is  in  the  case  of 
HBGF-2. In both cases the cells round up and become more 
phase bright, but neurites are still present in over 70 % of the 
cells grown in NGF but in <5 % of cells with HBGF-2. The 
amphiphilic peptide F (residues 24-68) does not block NGF- 
induced neurite outgrowth. 
HBGF-2-induced SupraceUular Assemblies 
Basement membranes can dramatically effect the morpho- 
logical differentiation of a tissue (see, e.g., reference 9).  If 
culture conditions could be devised where basement mem- 
brane-like structures influence the type of cell-cell interac- 
tions seen in vivo, then it may be possible to gain some in- 
sight  into  the  chemistry  of the  cell-basement membrane 
interactions  that  are  responsible  for  these  events.  Since 
HBGF-2 can bind heparin it is probable that it is associated 
with heparin-rich basement membranes and therefore may 
influence cells that interact with that membrane. To construct 
artificial basement membranes on the  substrata of culture 
dishes,  tissue culture dishes were first coated with poly-L- 
lysine and then with either chondroitin  sulfate or heparin. 
HBGF-2 was added to some of the dishes overnight and the 
dishes were washed extensively. The effect of these different 
substrata on the cells was then assayed. Fig. 4 shows that in 
the absence of HBGF-2, cells on both heparin (Fig. 4 A) and 
Figure 4. Effect of  artificial matrices on cellu- 
lar interactions. PCI2 cells were plated upon 
the  surfaces  indicated  below  at  1  x  10  s 
cells/35-mm  culture  dish and photographed 
4 d  later. The  cell  diameter  is  '~20  pro. 
These  experiments  have  been  repeated  at 
least 12 times with similar results. A detailed 
kinetic and ultrastructural  analysis of circle 
formation will be presented  elsewhere.  (A) 
Chondroitin sulfate. (B) Chondroitin  sulfate 
plus HBGF-2.  (C) Chondroitin  sulfate plus 
HBGF-2 plus  100  gg/ml of peptide  F.  (D) 
Heparan  sulfate. (E)  Heparan  sulfate plus 
HBGF-2.  (F) Heparan sulfate plus HBGF-2 
plus peptide E 
Schubert et al. Heparin-binding Growth Factor  639 chondroitin  sulfate (Fig.  4  D) have a  round,  phase-bright 
morphology,  and  that  the  cells  on  heparin  tend  to  form 
chains. However, in the presence of substrate-bound HBGF- 
2 or HBGF-2 added to the dishes directly, the arrangement 
of the cells on the culture dish changes dramatically. Cells 
plated on a matrix of chondroitin sulfate and HBGF-2 form 
circles consisting of 10-30 cells (Fig. 4 B). This process ap- 
parently takes place via the movement of cells over the sub- 
stratum since the cells are randomly distributed over the dish 
5 h after plating. HBGF-2 is only slightly mitogenic for PC12 
cells (5  +  2%  increase in cell number over control after 
3 d).  In contrast to cells plated on chondroitin  sulfate and 
HBGF-2, cells on the heparin HBGF-2 matrix form tight ag- 
gregates that are loosely attached to the substratum (Fig. 4 
E).  NGF adsorbed to these substrata causes the formation 
of some circles on chondroitin  sulfate and modest neurite 
outgrowth.  NGF on heparin causes very few aggregates to 
form. Although NGF produces changes in cellular behavior 
similar to those caused by HBGF-2, the latter is much more 
effective. 
Since some of the synthetic peptides that influence HBGF- 
2  binding  also block the  morphological differentiation of 
PC12 cells by HBGF-2, the peptides were assayed for their 
ability  to  inhibit  the  morphological  changes  caused  by 
HBGF-2 bound to the two glycosaminoglycans. Of the pep- 
tides tested (Table I) only the amphipathic 24-68 sequence 
(peptide F) blocks both circle formation on chondroitin sul- 
fate and aggregate formation on heparin (Fig. 4,  C and F). 
Peptide N (residues 93-120) causes the cells to become very 
flat, and, in the presence of soluble HBGF-2, grow long neu- 
rites,  but it does not block HBGF-2-induced formation of 
circles  on  chondroitin  sulfate  or  aggregate  formation  on 
heparin. 
Cell Viability 
Two populations of embryonic nerve cells were used to assay 
the effect of HBGF-2 on cell viability: 8-d embryonic chick 
ciliary ganglion and neural retina cells. The embryonic gan- 
glion cells normally die within 24 h in the absence of added 
trophic factors (see, e.g., references 14, 32) while the viabil- 
ity of the embryonic neural retina cells declines with a half- 
life of 3 d (43). To test the effect of HBGF-2 on the survival 
of  both cell populations, the cells were dissociated and plated 
in DME containing  either  10%  FCS  (ciliary ganglion)  or 
serum-free medium (neural retina cells) in the presence or 
absence of HBGF-2. Viable cell number was determined at 
24 h (ciliary ganglion) or at 1-d intervals (neural retina cells). 
Fig. 5 A shows that HBGF-2 did not alter the survival rate 
of dissociated neural retina cells.  Purpurin,  a  cell survival 
molecule for neural retina cells, was added to some dishes 
as a positive control. Fig. 5 B shows that HBGF-2 supported 
the survival of 8-d embryonic ciliary ganglion cells at a half 
maximal effectiveness of ,05 pM HBGF-2. These data show 
that HBGF-2 affects the survival of dissociated ciliary gan- 
glion cells but not that of neural retina cells from the same 
age embryo. When the ability of all the synthetic peptides to 
block the effect of HBGF-2 on ciliary cell survival was exam- 
ined,  only the amphiphilic HBGF-2 peptide F  of residues 
24-68 was effective. 
Discussion 
The above data show that HBGF-2 has several diverse effects 
on nerve cells in culture. These include increasing the rate 
of cell substratum adhesion (Fig. 2), the stimulation of neu- 
rite  formation (Fig.  3),  increased  cell  survival of ciliary 
nerve cells in primary cultures (Fig. 5), and, when adsorbed 
to artificial extracellular matrices,  the ability to cause the 
formation of circles  of cells or the  formation of cell  ag- 
gregates, depending upon the composition of the matrices 
(Fig. 4). When a series of synthetic peptides derived from 
the  HBGF-2 sequence  were examined  for their  ability  to 
block its biological effects, an amphiphilic peptide of HBGF- 
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Figure 5.  Effect of HBGF-2 on 
ciliary ganglion and neural retina 
survival.  (A) Neural  retina cells 
were  dissociated  from 8-d  em- 
bryos, plated at 2 x  104 cells/35- 
mm  tissue  culture  dish  coated 
with  polylysine,  and  the  viable 
cell number determined  daily as 
described in Materials and Meth- 
ods.  Concentrations  of HBGF-2 
up to 20 nM were tested without 
effect. As a positive control pur- 
purin  was added at 100 rig/dish. 
(open triangles) Control no addi- 
tive; (X) 100 pM HBGF-2; (open 
circles) purpurin. (B) Ciliary gan- 
glion cells were dissociated from 
8-d embryos as described in Mate- 
rials and Methods. The number of 
viable cells as determined 20 h af- 
ter plating in the indicated amounts 
of HBGF-2.  (open  circles  and 
open triangles) Two independent 
experiments with HBGF-2 (X) 10 
pM HBGF-2 plus  100  Ixg/ml of 
peptide  E  Similar  results  were 
obtained with FL 
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growth,  HBGF-2-induced circle and  aggregate formation, 
and the HBGF-2-dependent survival of ciliary cells.  This 
peptide  and  several  others  were  able  to  stimulate  cell- 
substratum adhesion. 
Several other proteins have been described that prolong 
the survival of neurons in culture. The best studied are NGF 
(27), a  12,300-D protein from pig brain (6), and a ciliary 
ganglion neurotrophic factor (5) that is similar if not iden- 
tical to purpurin, a 20,000-D protein that inhibits the death 
in culture of both embryonic neural retina and ciliary gan- 
glion cells (43, 46). HBGF-2 is a protein mitogen for most 
anchorage-dependent primary  cultures  (4)  and  there  has 
been a recent report that it increases the survival of cells in 
primary cultures of rat hippocampus (53). Fig. 5 shows that 
HBGF-2 has the ability to promote the survival of cultured 
embryonic chick ciliary ganglion cells but not chick neural 
retina cells. In contrast purpurin, an eye derived molecule, 
promotes the  survival  of both populations  (46).  HBGF-2 
therefore shows some cell-type specificity with respect to en- 
hancing nerve cell survival. Both HBGF-2 and purpurin in- 
crease cell-substratum adhesion and laminin, an exception- 
ally potent adhesion promoting molecule, also causes nerve 
cell survival (7). 
Numerous studies have shown that there is a relationship 
between cellular adhesion and division, and it is likely that 
these observations can be extended to cell survival. Folkman 
and Moscona (19) showed that small changes in cell shape, 
which is directly influenced by cell-substratum  adhesion, 
have large effects upon the probabilities of initiating DNA 
synthesis. The more spread a cell the greater the likelihood 
of DNA synthesis (see also 37).  There is also a correlation 
between cell shape and physiology. When cells that are an- 
chorage dependent for growth (49) are placed in suspension 
culture they rapidly become arrested in the Gj phase of the 
cell cycle (38) and RNA and protein synthesis is rapidly de- 
creased (8, 18). They eventually die (18, 19). It has been ar- 
gued that these phenotypic changes may be due to differences 
in nutrient transport between more and less spread cells (22). 
Since (a) HBGF-2 only stimulates mitosis in substrate at- 
tached cells, (b) HBGF-2 does not stimulate DNA synthesis 
when a HBGF-2-responsive cell line is cultured in suspen- 
sion (47),  and (c) HBGF-2 promotes the adhesion of cells 
(Fig. 2), it follows that one of the mechanisms that mediates 
the effects of HBGF-2 may be to increase cell-substratum 
adhesion and therefore cell spreading. The efficiency of this 
interaction is dictated by the composition of the extracellular 
matrix. 
Components of the extracellular matrix can influence the 
migration and differentiation of juxtapositioned cells  (see 
reference 9 for a review). Within the nervous system the role 
of extracellular matrix components such as heparan sulfate 
is only recently becoming appreciated. In addition to HBGF- 
2, several other molecules bind specifically to heparin and 
heparan sulfate. These include purpurin (46), N-CAM (12, 
13), the well characterized basement membrane component 
laminin (7,  15), and flbronectin (11). The heparin binding 
fragment of laminin alone promotes nerve cell survival and 
neurite outgrowth (15). A neurite promoting activity, thought 
to be laminin,  has  also been isolated from an extracellu- 
lar  macromolecular  complex  containing  heparan  sulfate 
proteoglycan (25).  In  addition  myelination is  initiated  by 
Schwann cell interactions with a nerve cell surface heparan 
sulfate proteoglycan (39). These data suggest that the interac- 
tions between the extraceUular environment and cell surface 
heparan sulfate proteoglycans have profound effects within 
the developing nervous system. Since most of the molecules 
that can bind heparin and heparan sulfate are released from 
cells, it is likely that they are localized within the matrix. 
Thus one of the functions of heparin binding may be to keep 
the secreted molecule near its cell of origin via entrapment 
in the matrix. Once in the matrix molecules such as HBGF-2 
may support cell adhesion, cell survival, and direct neurite 
outgrowth. Upon release from the matrix they become po- 
tent mitogens. 
It has been reported elsewhere that HBGF-2 causes neurite 
extension in PC12 cells and that there is spontaneous retrac- 
tion of neurites after 6 d, even in the continued presence of 
HBGF-2 (52).  In these experiments,  substantially greater 
concentrations of HBGF-2 were required to cause neurite 
outgrowth than those reported here and there was no indica- 
tion of the purity of their protein. Since we do not observe 
that the neurites retract in the continued presence of HBGF-2 
except when the cultures became very dense, it is possible 
that contaminants in the HBGF-2 preparations of Togari et 
al.  (52) were adversely effecting the cells. In addition, the 
cultures  described  here  were  maintained  in  polylysine- 
coated substrata  and  serum-free N2  media  as  opposed to 
serum-containing media.  Serum tends to reduce cell-sub- 
stratum  adhesion  and  cause  neurite  retraction (45).  It  is 
clear, however, that while NGF and HBGF-2 both affect neu- 
rite outgrowth in PC12 cells, their effects are not identical. 
There are, for example, differences in neurite morphology 
between HBGF-2- and NGF-induced cells, for those caused 
by HBGF-2 are more straight than those made by NGF (Fig. 
3).  Moreover, the maximum rate of neurite outgrowth and 
neurite arborization are somewhat lower in HBGF-2-treated 
cultures relative to those exposed to NGE  It is likely that 
NGF and HBGF-2 share a subset of events that leads to neu- 
rite elongation, but that not all of the chemistry involved is 
identical. As suggested before (52), this situation is analo- 
gous to that with cAMP,  which can mimic the short term 
effects of NGF but not all of its long term effects (42). 
The experiments showing that HBGF-2 can affect cell-cell 
interactions in culture (Fig. 4) suggest that it may play a role 
in morphogenesis. Although the mechanisms involved in the 
formation of circles of cells or cellular aggregates are not 
known, it is likely that they involve the ability of HBGF-2 
to modulate the adhesive properties of cells to the substra- 
tum. As initially outlined by Steinberg (48) in his differential 
adhesion hypothesis, changes in the relative adhesiveness of 
cells to each other and to their environment can have pro- 
found effects on the topological distribution of cells within 
a "closed" system. The combination of HBGF-2 and glycos- 
aminoglycans must influence the adhesiveness of the PC12 
cells such that on heparin they are less adhesive to the sub- 
stratum  than to themselves  (aggregate formation),  on the 
glycosaminoglycans alone they adhere more tightly to the 
substrata (single attached cells), and on the combination of 
chondroitin  sulfate and  HBGF-2 they have an  intermedi- 
ate adhesiveness to each other and the  substratum  (circle 
formation). 
Of the 16 synthetic peptides that cover the entire sequence 
of the HBGF-2 molecule, only peptides D  (residues  106- 
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binding of L25I-HBGF-2 to cells (Table I), while peptides F, 
N, and E (NH2-terminal 24 residues) stimulate cell-substra- 
tum adhesion (Table I). All of these peptides have a net posi- 
tive charge at neutrality and peptide F has two internal am- 
phiphilic or 13-sheet sequences. An amphiphilic or [3-sheet 
sequence is one that causes a segregation of hydrophobic and 
hydrophilic residues when the secondary structure is formed. 
This can occur when the peptide has alternating hydrophobic 
and  hydrophilic  residues.  Such  peptides  can  form  stable 
13-sheet structures so that the hydrophobic amino acids pro- 
ject above and the hydrophilic below the plane of the peptide. 
Amphiphilic 13-sheets should interact strongly with cellular 
membranes,  for the  hydrophobic residues  should  interact 
with the hydrophobic aspect of the membrane, whereas the 
hydrophilic residues should interact with the cell surface gly- 
coproteins or aqueous environment. Peptide hormones with 
amphiphilic secondary structures interact strongly with cell 
membranes and this interaction is critical for their biological 
activities (23). A study of  both natural and synthetic peptides 
suggested that most amphiphilic peptides with a net charge 
of >+2  interact with cells and promote adhesion (40). In 
contrast the  common polycations such  as  polylysine and 
polyornithine must have a net charge of +10 or more to medi- 
ate adhesion (33). The data presented here are only in partial 
agreement with these conclusions. Of the three HBGF-2 se- 
quences that block ~25I-HBGF-2  binding to ceils or promote 
cell-substratum adhesion when adsorbed to a plastic surface, 
only one contains amphiphilic  sequences; two have a  net 
charge of >+2. The NHE-terminal peptide E, residues 1-24, 
has a net charge of +1 and no alternating hydrophobic and 
hydrophilic residues. It promotes cell adhesion but is rela- 
tively ineffective in blocking HBGF-2 binding.  Peptide F 
(residues 24-68) contains two amphiphilic sequences, Leu- 
Arg-Ile-His-Pro-Asp and Asp-Pro-His-Ile-Lys-Leu-G1N- 
Leu-G1N-Ala-Glu, and has a net charge of +3. The last bio- 
logically active peptide N (residues 93-120) has a charge of 
+5, but no amphiphilic sequence. However, neither charge 
nor amphiphilic secondary structure, nor the combination of 
the two is sufficient to cause adhesion. Peptide H (residues 
121-146) has a net charge of +5 and an amphiphilic series 
of  residues,  G1N-Tyr-Lys-Leu-Gly-Pro-Lys and  Gly-Pro- 
Gly, but it is totally inactive in promoting cell-substratum 
adhesion or blocking the binding of HBGF-2 to cells. These 
data suggest that peptides F  and N  have unique sequences 
that allow them to both block HBGF-2 binding and promote 
cellular adhesion. The receptors for these sequences must be 
on many cell types for they stimulate the adhesion of most 
cell types (unpublished observation). This is not surprising 
since a HBGF-2 is mitogenic for most cell types in primary 
culture. How is it possible, however, that peptides F and N 
both block HBGF-2 binding to cells but that only peptide F 
can block the biological responses of cells to HBGF-2? It is 
probable that peptide N is either more rapidly degraded or 
has a relatively low affinity for the cell surface HBGF-2 bind- 
ing site. It may also adsorb nonspecifically to the surface of 
cells or the substratum during the long term (1-2 d) duration 
of the biological assays and therefore not compete effectively 
with the higher affinity binding of HBGF-2. In contrast, the 
~25I-HBGF-2 binding assay only takes 2 h and the nonspe- 
cific adsorption may be relatively less. Clearly more work 
is required to understand the details of the HBGF-2-cell in- 
teraction, but the  use of the  synthetic peptides  described 
above should allow for a better understanding of this interac- 
tion at the cell surface. These peptides should also prove use- 
ful in vivo for elucidating the possible role of HBGF-2 in 
neuronal development. 
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